DWM
NMTR

Dynasty Wealth Management’s 9 Meters Biopharma NMTR Stock Holding History

Dynasty Wealth Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,779
Closed -$243K – 117
2018
Q3 		$243K Buy
1,779
+935
+111% +$161K 0.31% 95
2018
Q2 		$398K Buy
844
+15
+2% +$5.52K 0.82% 30
2018
Q1 		$454K Buy
829
+99
+14% +$19.3K 0.19% 24
2017
Q4 		$89K Buy
+730
New +$93.6K 0.15% 96

Other funds holding NMTR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Dynasty Wealth Management's NMTR Position: Q4 2018 in Review

Dynasty Wealth Management sold out of 9 Meters Biopharma (NMTR) in Q4 2018, closing a stake of 1,779 shares — an estimated $243K sold.

Dynasty Wealth Management first reported a position in NMTR in Q4 2017 and held it in 4 quarters. The position peaked at $454K in Q1 2018. 39 funds tracked by Wall St. Rank hold NMTR as of Q4 2018.

  • Dynasty Wealth Management reported no remaining 9 Meters Biopharma position as of Q4 2018 after selling out during the quarter.
  • Dynasty Wealth Management sold 1,779 9 Meters Biopharma shares in Q4 2018, an estimated $243K.
  • Dynasty Wealth Management first reported a position in 9 Meters Biopharma in Q4 2017 and held it in 4 quarters.
  • Dynasty Wealth Management's 9 Meters Biopharma position peaked at $454K in Q1 2018.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2018.

Based on Dynasty Wealth Management's 13F filing for Q4 2018, filed 12 Feb 2019.